• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Global Small-Cell Lung Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: 4SC, Amgen, Johnson & Johnson - Research and Markets

    Global Small-Cell Lung Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: 4SC, Amgen, Johnson & Johnson - Research and Markets

  2. Global Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: AbbVie, Bavarian Nordic, ...

    Global Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: AbbVie, Bavarian Nordic, GTx - Research and Markets

  3. Global Oropharyngeal Cancer Pipeline Report 2016 - Research and Markets

    Global Oropharyngeal Cancer Pipeline Report 2016 - Research and Markets

  4. Global Bladder Cancer Pipeline Report 2016 - Review of 94 Companies & Drug Profiles - Research and Markets

    Global Bladder Cancer Pipeline Report 2016 - Review of 94 Companies & Drug Profiles - Research and Markets

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.